Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Zilbrix and Tritanrix-HepB Co-administered with Rotarix in Infants
NCT00158756Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Primary completion
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Tritanrix-HepB in diphtheria, Tetanus, pertussis, hepatitis B (HBV), sponsored by GSK. Started Sep 2005; status: completed.
02
Drugs
Tritanrix-HepB
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)
Beyond the preview
Go deeper on NCT00158756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158756.